Skip Navigation

Link to  the National Institutes of Health  
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Archives of the National Institute on Drug Abuse web site
Go to the Home page

Director's Report to the National Advisory Council on Drug Abuse
May, 2002

Extramural Policy and Review Activities


For this Council cycle, the Office of Extramural Affairs (OEA) arranged and managed 14 review meetings for grant applications including those in standing review committees, applications in conflict-of-interest with standing committees, and submissions to special initiatives. In addition, OEA arranged and managed fourteen contract proposal review meetings.

The reviews for NIDA's chartered committees were held. These consist of NIDA-E (Treatment Review Committee), NIDA-F (Health Services Review Committee), NIDA-L (Medications Development Committee), and NIDA-K (Training Committee). Five Special Emphasis Panels were held to review applications in conflict with the chartered committees. Three Special Emphasis panels were constituted for reviews of specific mechanisms: centers, program projects, and conference grant applications. In addition, OEA staff managed the reviews for B/START and Cutting Edge Basic Research Award (CEBRA) mechanisms.

The Contracts Review Branch managed the following proposal reviews:

N01DA-2-8821 Purity Specifications, Storage and Distribution for Medication Development
N43DA-2-5508 Develop Prevention Services Analytic Tools for Improved Substance Abuse Prevention Delivery.
N43DA-2-5513 Develop and Maintain Substance Abuse Prevention Methodological Software
N43DA-2-5518 Prevention Training (Fast Track: Phase I and Phase II proposals)
N43DA-2-7709 Virtual Reality for the Treatment of Pain (Fast Track)
N43DA-2-7730 High-Throughput Screening of Functional Activity Proteins Using Biosensor-based Technology
N43DA-2-7727 Analytical Techniques Program (Fast Track)
N43DA-2-7714 Technologies for Localizing Gene Expression and Proteins in the Nervous System
N01DA-2-2202 Administrative and Meeting Support for the CTN
N43DA-2-7726 Functional Imaging Agents
N43DA-2-8819 Medicinal Chemistry-Design and Synthesis (Fast Track)
N43DA-2-5517 Develop New Technologies for Drug Abuse Prevention Delivery
N43DA-2-8820 Dosage Form Development
N43DA-2-1109 Development of Science Education

Staff Training, Policy Development, and Extramural Activities

The OEA Symposium Series continued its monthly meetings for staff development, under the direction of Dr. Mark Swieter, SRA, Basic Sciences Review Branch. These sessions included a question and answer session with Dr. Glen Hanson, Acting Director, NIDA and Ms. Laura Rosenthal, Executive Officer and Associate Director, NIDA. Other sessions presented updates on and discussion of NIH extramural policies.

On March 1, 2002, Dr. Swieter gave a talk on the NIH Grants Enterprise to the NIDA INVEST and Humphrey fellows.

In anticipation of broader use of technology in peer review, Dr. Marina Volkov, SRA, Clinical, Epidemiological, and Applied Sciences Review Branch (CEASRB) and Ms. Marilyn Thomas, GTA, CEASRB, pilot tested a WEB based module for peer review for their February study section meeting.

Mr. Richard Harrison, Chief, Contracts Review Branch, has served as a reviewer for a number of minority-related initiatives, including: Administrative Supplement Applications for the NIDA Health Disparities Committee; Minority Supplement Applications for NIDA's Consortium on Minority Affairs, and Administrative Supplements for NIDA's Southern Africa Initiative.

Mr. Eric Zatman, Contracts Review Branch, continues to serve on the NIH committee revising the Contract manual "Initiation, Review, Evaluation and Award of Research & Development Contract Projects." This manual chapter guides policy for the review of contract proposals.

[Office of the Director][Report Index][Next Report Section]

Archive Home | Accessibility | Privacy | FOIA (NIH) | Current NIDA Home Page
National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. . The U.S. government's official web portal